Stamford, CT -- (SBWIRE) -- 01/08/2014 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Neurocrine Biosciences, Inc. (NASDAQ:NBIX), Epizyme Inc (NASDAQ:EPZM), FuelCell Energy Inc (NASDAQ:FCEL), Cray Inc. (NASDAQ:CRAY)
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) opened the session at $15.70, trading in a range of $15.20 - $18.62. The stock showed a positive performance of +89.69% in the last trading session from its previous close of $9.76 and closed at $18.51. The stock traded on a volume of 18.98 million shares and the average volume of the stock remained 563,232 shares. Neurocrine Biosciences, Inc. engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. It develops drugs for endometriosis, tardive dyskinesia, uterine fibroids, stress-related disorders, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders.
For How Long NBIX will Fight for Profitability? Read This Trend Analysis report
Epizyme Inc (NASDAQ:EPZM) traded 3.81 million shares in the last business day while the average volume of the stock remained 223,637 shares. The stock showed a positive movement of +75.56% to end at $35.99. The 52 week range of the stock remained $18.10 - $45.72. Epizyme, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, planning, and commercialization of various personalized therapeutics for the treatment of patients with genetically defined cancers. Its principal product candidates under development include EPZ-5676, an intravenously administered small molecule inhibitor of DOT1L that is in Phase I clinical trials for the treatment of mixed lineage rearranged leukemia (MLL-r); and EPZ-6438, an orally available small molecule inhibitor of EZH2 for the treatment of non-Hodgkin lymphoma patients caused by an oncogenic point mutation in EZH2.
For How Long EPZM’s Gloss will Attract Investors? Find out via this report
FuelCell Energy Inc (NASDAQ:FCEL) reported 20.21 million shares were exchanged during the last trade, while the average volume is about 5.66 million shares. The stock escalated 15.22% and finished the day at $1.86. The beta of the stock is recorded at 2.16. FuelCell Energy, Inc., together with its subsidiaries, designs, manufactures, sells, installs, operates, and services stationary fuel cell power plants for distributed baseload power generation. It offers Direct FuelCell power plants that electrochemically produce electricity and heat using various fuels, including natural gas, methanol, diesel, biogas, coal gas, coal mine methane, and propane.
For How Long FCEL’s Gloss will Attract Investors? Find out via this report
Cray Inc. (NASDAQ:CRAY) shares rose, +14.62 percent from its previous close of $27.16 to close at $31.13. Traded with volume of 1.91 million shares in the prior session and the average volume of the stock remained 313,619 shares. Cray Inc., together with its subsidiaries, designs, develops, manufactures, markets, and services high-performance computing (HPC) systems. The company offers a range of supercomputer systems that comprise Cray XC30, Cray XK7/XK7m, and Cray XE6/XE6m systems; and Cray Xtreme-X and Cray Xtreme-Cool supercomputers.
Why Should Investors Buy CRAY After The Recent Gain? Just Go Here and Find Out
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)